Glucocorticoids can induce BIM to trigger apoptosis in the absence of BAX and BAK1

被引:10
|
作者
Dong, Li [1 ,2 ]
Vaux, David L. [1 ,2 ]
机构
[1] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CYTOCHROME-C; BH3-ONLY PROTEINS; PROAPOPTOTIC BAX; LYMPHOID-CELLS; BCL-2; RELEASE; APAF-1;
D O I
10.1038/s41419-020-2599-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cells from two murine lymphoid lines died 24-48 h after treatment with the glucocorticoid dexamethasone. Deletion of Bax and Bak1 prevented rapid apoptosis, but treatment with dexamethasone for greater 6 days still led to cell death that was characterized by release of cytochrome c into the cytosol, activation of caspases, and loss of cell membrane integrity. In WEHI7 thymoma cells, this did not occur when Bcl2l11 (Bim) was deleted in addition to Bax and Bak1. When these triple mutant lines were exposed to dexamethasone for 10 days, they arrested, but after dexamethasone was removed, they had 10-fold higher clone forming efficiency than Bax/Bak1 double knock-out cells. Although induced over-expression of BIMs alone was not sufficient to induce the death of Bax(-/-)Bak1(-/-)Bim(-/-) cells, they did die when BIMs was induced in the presence of dexamethasone. These results suggest that dexamethasone induces production of BIM together with other, as yet unidentified proteins, that cause release of cytochrome c and apoptosis in the absence of BAX and BAK1.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Glucocorticoids can induce BIM to trigger apoptosis in the absence of BAX and BAK1
    Li Dong
    David L. Vaux
    Cell Death & Disease, 11
  • [2] Modeling apoptosis resistance in CHO cells with CRISPR-mediated knockouts of Bak1, Bax, and Bok
    MacDonald, Michael A.
    Barry, Craig
    Groves, Teddy
    Martinez, Veronica S.
    Gray, Peter P.
    Baker, Kym
    Shave, Evan
    Mahler, Stephen
    Munro, Trent
    Marcellin, Esteban
    Nielsen, Lars K.
    BIOTECHNOLOGY AND BIOENGINEERING, 2022, 119 (06) : 1380 - 1391
  • [3] Bax/Bak activation in the absence of Bid, Bim, Puma, and p53
    Zhang, J.
    Huang, K.
    O'Neill, K. L.
    Pang, X.
    Luo, X.
    CELL DEATH & DISEASE, 2016, 7 : e2266 - e2266
  • [4] Bax/Bak activation in the absence of Bid, Bim, Puma, and p53
    J Zhang
    K Huang
    K L O'Neill
    X Pang
    X Luo
    Cell Death & Disease, 2016, 7 : e2266 - e2266
  • [5] Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis
    Zong, WX
    Li, C
    Hatzivassiliou, G
    Lindsten, T
    Yu, QC
    Yuan, JY
    Thompson, CB
    JOURNAL OF CELL BIOLOGY, 2003, 162 (01): : 59 - 69
  • [6] Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons
    Martinou, I
    Missotten, M
    Fernandez, PA
    Sadoul, R
    Martinou, JC
    NEUROREPORT, 1998, 9 (01) : 15 - 19
  • [7] Low Probability Activation of Bax/Bak Can Induce Selective Killing of Cancer Cells by Generating Heterogeneity in Apoptosis
    Raychaudhuri, Subhadip
    Das, Somkanya C.
    JOURNAL OF HEALTHCARE ENGINEERING, 2013, 4 (01) : 47 - 66
  • [8] Stepwise Activation of BAX and BAK by tBID, BIM, and PUMA Initiates Mitochondrial Apoptosis
    Kim, Hyungjin
    Tu, Ho-Chou
    Ren, Decheng
    Takeuchi, Osamu
    Jeffers, John R.
    Zambetti, Gerard P.
    Hsieh, James J. -D.
    Cheng, Emily H. -Y.
    MOLECULAR CELL, 2009, 36 (03) : 487 - 499
  • [9] Proteasome inhibitors induce a BAX and BAK independent, non-canonical apoptosis
    Mukiza, Tresor O.
    Enrique-Rodriguez, Ricardo
    Budhraja, Amit
    Brakefield, Lauren
    Moldoveanu, Tudor
    Opferman, Joseph T.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [10] Embryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK
    Ke, Francine F. S.
    Vanyai, Hannah K.
    Cowan, Angus D.
    Delbridge, Alex R. D.
    Whitehead, Lachlan
    Grabow, Stephanie
    Czabotar, Peter E.
    Voss, Anne K.
    Strasser, Andreas
    CELL, 2018, 173 (05) : 1217 - +